Posted by Surbhi on July 09 2026 at 06:02 PM
public
IL-23 inhibitors in IBD treatment — the selective biologics targeting the p19 subunit of interleukin-23 (risankizumab/Skyrizi, guselkumab/Tremfya, mirikizumab/Omvoh) demonstrating superior effica...
The Asia Pacific biologics contract manufacturing market is entering a high-growth phase, supported by rising biopharmaceutical demand, expanding biologics pipelines, and increasing outsourcing a...
In today’s highly competitive and rapidly evolving business landscape, having access to accurate and actionable market intelligence has become more important than ever. Organizations across indus...
The Retinal Biologics Market research report has been crafted with the most advanced and best tools to collect, record, estimate, and analyze market data. The report also sheds light on the marke...
Posted by Amit m on June 17 2026 at 07:10 PM
public
The global spine biologics market is experiencing steady growth as healthcare providers increasingly adopt regenerative therapies and advanced biologic solutions to treat spinal disorders. Valued...
